ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
6,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
7,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
8,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
9,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
10,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
10,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
10,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
11,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
11,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
11,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,4,Headache,Headaches NEC,Headaches,Nerv,N
11,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
12,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
13,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
13,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
14,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
14,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
14,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
14,6,Headache,Headaches NEC,Headaches,Nerv,N
14,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,8,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
15,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
16,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
16,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
17,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
18,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
20,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
20,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
20,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
20,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
21,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
22,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
22,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
22,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
22,6,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
23,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
23,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
23,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
23,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
23,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
24,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
25,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
26,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
27,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
28,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
28,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
29,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
30,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
31,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
32,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
33,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
33,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
33,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
34,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
34,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,5,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
34,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
34,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
34,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
34,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
35,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
36,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
36,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
36,3,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
37,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
37,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
37,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
37,4,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
37,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
38,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
39,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
39,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
40,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
41,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
42,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
43,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
44,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
44,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
44,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
44,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
44,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
45,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
47,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
47,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
47,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
47,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
47,5,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
47,6,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
47,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
48,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
48,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
48,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
49,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
49,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
49,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
49,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
49,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
49,6,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
49,7,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
49,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
49,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
49,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
49,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
50,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
51,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
52,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
53,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
53,2,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
53,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
54,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
54,2,Headache,Headaches NEC,Headaches,Nerv,N
54,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
55,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
55,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
55,3,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
56,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
57,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
58,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
58,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
58,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
58,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
59,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
60,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
61,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
62,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
62,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
62,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
63,1,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
64,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
65,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
66,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,1,Alveolar proteinosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
67,2,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
67,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
67,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
67,6,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,Y
67,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
67,8,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
67,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
68,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
68,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
68,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
69,1,Cerumen impaction,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
69,2,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
69,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
69,4,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
70,2,Cerumen impaction,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
70,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
70,4,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
70,5,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,6,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
71,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
72,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
73,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
73,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
74,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
74,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
75,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
75,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
75,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
75,4,Headache,Headaches NEC,Headaches,Nerv,N
75,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
75,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
75,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
75,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
76,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
77,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
77,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
77,5,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
77,6,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
77,7,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
78,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
79,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
79,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
79,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
79,4,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
79,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
79,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
79,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
79,8,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
79,9,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
79,10,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
79,11,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
79,12,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
79,13,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
79,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
79,15,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
80,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
80,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
80,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
81,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
82,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
82,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
82,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
83,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
84,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
85,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
86,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,2,Creatinine renal clearance increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
87,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
87,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
87,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
87,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
87,5,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
87,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
87,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
88,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
89,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
90,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
91,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
91,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
91,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
92,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
93,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
94,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
95,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
95,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
96,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
96,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
96,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
97,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
99,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
99,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
99,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
100,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
100,2,Headache,Headaches NEC,Headaches,Nerv,N
100,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
100,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
100,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
101,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
102,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
103,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
104,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
104,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
105,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
106,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
107,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
107,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
107,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
108,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
108,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
108,3,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
109,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
109,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
111,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
112,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
113,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
114,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
115,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
115,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
116,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
117,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
118,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
119,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
120,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
121,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
121,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
122,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
122,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
123,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
123,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
124,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
126,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
127,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
128,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
129,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
129,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
129,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
129,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
129,5,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
130,1,Anticonvulsant drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
130,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
131,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
131,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
131,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
132,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
133,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
134,1,Pseudoporphyria,Bullous conditions,Epidermal and dermal conditions,Skin,N
135,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
136,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
136,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
137,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
137,2,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
137,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,4,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
138,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
139,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
140,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
141,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
142,1,Colour blindness acquired,Colour blindness (incl acquired),Vision disorders,Eye,N
142,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
142,3,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
142,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
143,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
144,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
144,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
144,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
145,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
145,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,3,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
146,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
146,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
147,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
147,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
147,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
147,4,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
147,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
148,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
149,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
150,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
151,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
152,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
153,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
154,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
154,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
154,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
154,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
154,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
154,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
155,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
155,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
156,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
156,2,Ephelides,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
156,3,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
156,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
156,5,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
156,6,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
157,1,Ephelides,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
157,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
158,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
159,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
159,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
159,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
160,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
160,2,Electromyogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
160,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
160,4,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
161,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
161,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
162,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
163,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
164,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
164,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
165,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
165,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
165,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
165,4,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
166,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
166,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
166,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
166,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
167,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
168,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
168,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
169,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
169,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
169,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
170,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
170,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
171,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
172,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
173,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
173,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
174,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
174,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
175,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
175,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
176,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
176,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
177,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
177,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
178,1,Blood alkaline phosphatase abnormal,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
178,2,Gamma-glutamyltransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
179,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
179,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
179,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
180,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
180,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
180,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
180,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
180,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
180,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
180,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
181,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
181,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
182,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
183,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
184,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
185,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
185,2,Ephelides,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
185,3,Lichenification,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
185,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
185,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
185,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
186,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
186,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
187,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
187,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
188,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
188,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
188,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
189,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
190,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
191,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
192,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
194,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
194,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
194,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
195,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
195,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
195,3,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
195,4,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
195,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
195,6,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
195,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
196,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
197,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
197,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,1,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
198,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
198,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
199,1,Pseudoporphyria,Bullous conditions,Epidermal and dermal conditions,Skin,N
199,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
200,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
200,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
200,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
201,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
201,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
201,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
201,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
201,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
202,1,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
202,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
202,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
203,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
203,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
204,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
204,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
205,1,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
205,2,Ephelides,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
205,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
205,4,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
206,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
207,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
208,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
208,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
208,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
208,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
209,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
210,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
211,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
212,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
212,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
213,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
213,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
214,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
214,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
214,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
214,5,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
214,6,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
214,7,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
215,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
216,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
217,1,Deafness,Hearing losses,Hearing disorders,Ear,N
218,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
218,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
219,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
220,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
221,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
222,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
222,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
223,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
224,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
225,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
226,1,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
226,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
227,1,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
228,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
228,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
229,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
229,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
230,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
231,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
233,1,Deafness,Hearing losses,Hearing disorders,Ear,N
234,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
234,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
235,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
235,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
235,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
236,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
236,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
236,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
237,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
238,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
239,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
240,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
240,2,Narcolepsy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
241,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
241,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
242,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
242,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
242,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
243,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
243,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
244,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
244,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
244,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
244,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
245,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
246,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
246,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
247,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
248,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
249,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
250,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
250,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
250,3,Bedridden,Disability issues,Lifestyle issues,SocCi,N
250,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
250,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
250,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
251,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
252,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
253,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
254,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
254,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
254,3,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
255,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
255,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
255,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
256,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
257,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
258,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
259,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
259,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
259,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
259,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
259,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
259,8,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
260,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
260,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
260,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
260,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
260,5,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
261,1,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
261,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
261,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
262,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
263,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
263,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
263,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
264,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
264,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
265,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
265,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
266,1,Dilatation intrahepatic duct acquired,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
266,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
266,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
267,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
268,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
269,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
270,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
270,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
271,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
272,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
273,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
274,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
275,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
276,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
276,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
276,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
276,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
276,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
277,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
277,2,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
278,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
279,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
280,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
281,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
282,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
283,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
283,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
284,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
285,1,Dacryocanaliculitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
285,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,3,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
285,4,Keratitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
285,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
286,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
286,2,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
286,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
287,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
287,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
287,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
287,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
287,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
288,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
288,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
288,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
288,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
289,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
289,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
290,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
291,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
292,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
292,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
293,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
293,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
294,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
294,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
295,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
296,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
296,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
296,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
297,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
298,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
298,2,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
299,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
299,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
299,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
299,4,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
300,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
300,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
300,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
300,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
300,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
301,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
301,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
302,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
302,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
303,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
304,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
305,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
305,2,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
306,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
306,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
306,3,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
307,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
307,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
307,3,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
308,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
308,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
308,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
308,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
308,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
308,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
309,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
309,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
309,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
310,1,Chloropsia,Visual colour distortions,Vision disorders,Eye,N
310,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
310,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
311,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
312,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
312,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
313,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
314,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
314,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
315,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
315,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
315,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
316,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
317,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
317,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
317,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
317,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
318,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
318,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
318,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
318,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
318,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
318,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
318,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
318,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
318,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
318,10,Mycobacterium fortuitum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
318,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
318,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
318,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
318,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
318,15,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
318,16,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
319,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
319,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
320,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
321,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
322,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
322,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
322,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
323,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
323,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
323,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
323,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
323,5,Pneumonitis aspiration,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
323,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
323,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
323,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
324,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
325,1,Headache,Headaches NEC,Headaches,Nerv,N
325,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
326,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
327,1,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
327,2,Mucosal erosion,Mucosal findings abnormal,General system disorders NEC,Genrl,N
327,3,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
328,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
328,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
328,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
329,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
330,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
330,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
330,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
330,4,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
331,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
331,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
331,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
332,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
333,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
333,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
334,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
334,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
335,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
336,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
337,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
338,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
338,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
339,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
339,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
340,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
340,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
340,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
340,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
341,1,Lip injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
341,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
342,1,Aspergilloma,Aspergillus infections,Fungal infectious disorders,Infec,N
342,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
342,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
342,4,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
342,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
342,6,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
342,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
343,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
343,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
344,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
344,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
345,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
345,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
346,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
347,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
347,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
348,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
348,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
348,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
348,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
348,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
348,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
349,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
349,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
349,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
349,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
349,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
350,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
350,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
350,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
352,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
352,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
352,3,Fluorosis,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
352,4,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
353,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
353,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
354,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
355,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
356,1,Macular pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
356,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
356,3,Multiple lentigines syndrome,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
356,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
356,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
357,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
358,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
359,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
359,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
359,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
360,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
360,2,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
360,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
361,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
362,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
363,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
364,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
365,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
366,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
367,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
368,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
369,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
370,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
371,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
372,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
373,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
374,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
375,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
376,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
377,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
378,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
379,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
380,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
381,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
382,1,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
383,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
384,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
385,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
385,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
386,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
386,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
387,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
388,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
388,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
389,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
390,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
391,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
392,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
392,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
392,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
392,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
392,5,Headache,Headaches NEC,Headaches,Nerv,N
393,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
394,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
394,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
394,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
395,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
396,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
396,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
396,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
397,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
398,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
399,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
399,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
399,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
399,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
399,5,Discoloured vomit,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
399,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
400,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
401,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
401,2,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
402,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
402,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
402,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
403,1,Rhinophyma,Rosaceas,Skin appendage conditions,Skin,N
404,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
404,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
405,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
405,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
405,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
405,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
405,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
406,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
406,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
406,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
407,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
407,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
408,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
408,2,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
408,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
408,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
409,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
410,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
411,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
411,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
411,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
411,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
411,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
412,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
413,1,Atrophy of globe,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
413,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
413,3,Candida endophthalmitis,Candida infections,Fungal infectious disorders,Infec,N
413,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
413,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,6,Leukocoria,Ocular disorders NEC,Eye disorders NEC,Eye,N
414,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
414,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
415,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
416,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
417,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
418,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
418,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
419,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
419,2,Coagulation time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
419,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
419,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
419,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
419,6,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
419,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
419,8,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
419,9,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
420,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
421,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
422,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
422,2,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
423,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
423,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
423,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
424,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
425,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
425,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
425,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
425,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
426,1,Acute haemorrhagic leukoencephalitis,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
426,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
426,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
426,4,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
426,5,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
426,6,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
426,7,Cerebral mass effect,Structural brain disorders NEC,Structural brain disorders,Nerv,N
426,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
426,9,Culture tissue specimen positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
426,10,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
426,11,Intracranial mass,Structural brain disorders NEC,Structural brain disorders,Nerv,N
426,12,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
427,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
428,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
428,2,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
428,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
428,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
428,7,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
428,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
428,9,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
428,10,Sputum purulent,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
429,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
430,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
431,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
431,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
432,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
433,1,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
434,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
434,2,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
434,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
434,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
434,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
435,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
435,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
435,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
436,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
436,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
436,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
436,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
436,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
436,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
436,7,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
436,8,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
436,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
437,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
437,2,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
437,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
437,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
437,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
437,6,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
437,7,Hypothalamic pituitary adrenal axis suppression,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
437,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
438,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
439,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
440,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
440,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
441,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
441,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
442,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
443,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
443,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
444,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
445,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
445,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
445,3,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
446,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
446,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
446,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
447,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
447,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
448,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
448,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
449,1,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
449,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
449,3,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
449,4,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
449,5,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
450,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
450,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
451,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
451,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
451,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
452,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
452,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
453,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
453,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
454,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
455,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
455,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
456,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
457,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
457,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
457,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
458,1,Acanthamoeba keratitis,Amoebic infections,Protozoal infectious disorders,Infec,N
458,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
458,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
458,4,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
459,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
459,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
459,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
460,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
460,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
461,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
463,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
464,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
466,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
467,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
468,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
469,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
470,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
470,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
471,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
471,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
472,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
473,1,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
474,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
474,2,Xanthopsia,Visual colour distortions,Vision disorders,Eye,N
475,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
475,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
475,3,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
475,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
476,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
476,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
476,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
476,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
476,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
476,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
476,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
477,1,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
478,1,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
479,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
479,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
479,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
480,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
480,2,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
480,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
481,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
482,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
483,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
484,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
484,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
484,3,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
484,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
485,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
485,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
486,1,Chronic pulmonary histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
486,2,Coccidioidomycosis,Coccidioides infections,Fungal infectious disorders,Infec,N
486,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
486,4,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
486,5,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
486,6,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
486,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
486,8,Pulmonary infarction,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
486,9,Pulmonary vasculitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
486,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
487,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
487,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
487,3,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
487,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
487,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
487,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
487,7,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
487,8,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
487,9,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
488,1,Cerebral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
488,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
488,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
488,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
488,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,6,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
488,7,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
488,8,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
488,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
488,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
488,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
488,12,Intracardiac mass,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
488,13,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
488,14,Noninfective encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
488,15,Oral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
488,16,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
488,17,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
488,18,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
488,19,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
488,20,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
489,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
489,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
490,1,Cervical spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
490,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
490,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
490,4,Osteitis deformans,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
490,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
490,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
490,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
491,1,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
492,1,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
493,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
493,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
493,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
493,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
493,5,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
493,6,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
493,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
493,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
494,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
494,2,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
495,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
496,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
496,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
497,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
498,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
498,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
499,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
499,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
500,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
501,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
501,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
502,1,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
503,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
503,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
504,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
504,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
505,1,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
505,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
505,3,Meningitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
505,4,Metabolic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
506,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
506,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
506,3,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
506,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,5,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,Y
506,6,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
506,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
506,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
506,9,Right atrial hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
506,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
506,11,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
507,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
508,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
508,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
508,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
509,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
509,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
509,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
509,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
510,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
510,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
510,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
511,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
511,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
511,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
512,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
513,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
514,1,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
514,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
514,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
514,4,Visual brightness,Visual disorders NEC,Vision disorders,Eye,N
515,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
515,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
516,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
516,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
516,3,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
516,4,Headache,Headaches NEC,Headaches,Nerv,N
516,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
517,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
517,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
517,3,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
518,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
519,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
519,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
519,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
519,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
520,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
520,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
520,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
521,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
521,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
521,3,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
522,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
522,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
523,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
523,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
524,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
524,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
525,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
526,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
526,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
526,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
526,5,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
527,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
527,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
527,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
527,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
527,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
527,6,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
528,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
529,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
530,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
530,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
530,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
531,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
531,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
531,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
531,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
531,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
532,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
532,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
532,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
533,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
533,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
534,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
534,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
535,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
535,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
536,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
536,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
537,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
538,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
538,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
538,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
538,4,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
539,1,Antibiotic level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
539,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
539,3,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
540,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
541,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
542,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
543,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
544,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
544,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
545,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
545,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
546,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
546,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
547,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
547,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
548,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
548,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
549,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
549,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
550,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
551,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
552,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
552,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
553,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
553,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
554,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
554,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
555,1,Metastatic lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
555,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
555,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
556,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
556,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
557,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
557,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
558,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
558,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
559,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
560,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
561,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
561,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
561,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
561,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
561,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
561,6,Visual field defect,Visual field disorders,Vision disorders,Eye,N
562,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
563,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
564,1,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
565,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
566,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
567,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
567,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
567,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
567,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
567,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
567,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
567,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
568,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
568,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
568,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
569,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
569,2,Dacryocanaliculitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
569,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
569,4,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
569,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
569,6,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
569,7,Keratitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
569,8,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
570,1,Skin neoplasm excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
571,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
572,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
573,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
574,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
575,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
576,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
578,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
579,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
580,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
581,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
582,1,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
582,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
583,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
583,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
583,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
584,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
584,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
585,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
585,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
586,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
587,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
587,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
588,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
588,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
589,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
589,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
590,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
590,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
591,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
591,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
592,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
593,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
594,1,Cholestatic liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
595,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
596,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
597,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
597,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
597,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
598,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
598,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
599,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
599,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
600,1,Aspergillus test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
600,2,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
600,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
600,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
600,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
600,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
600,7,Procalcitonin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
600,8,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
601,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
601,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
601,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
601,4,Migraine,Migraine headaches,Headaches,Nerv,N
601,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
602,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
603,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
604,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
604,2,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
605,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
606,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
606,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
607,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
607,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
608,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
608,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
609,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
609,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
609,3,Cerebral microhaemorrhage,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
609,4,Granuloma,Inflammations,General system disorders NEC,Genrl,N
609,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
610,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
611,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
611,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
611,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
611,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
611,5,Hepatosplenic candidiasis,Candida infections,Fungal infectious disorders,Infec,N
611,6,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
611,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
611,8,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
612,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
613,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
613,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
614,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
614,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
614,3,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
614,4,Headache,Headaches NEC,Headaches,Nerv,N
614,5,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
614,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
614,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
614,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
614,9,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
614,10,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
614,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
615,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
615,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
615,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
616,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
617,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
617,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
617,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
618,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
618,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
619,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
620,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
621,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
622,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
623,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
624,1,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
625,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
626,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
626,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
626,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
627,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
628,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
629,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
629,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
630,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
630,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
631,1,Abscess fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
631,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
631,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
631,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
631,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
631,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
631,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
631,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
631,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
631,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
631,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
631,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
632,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
632,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
632,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
632,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
632,5,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
633,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
633,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
633,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
633,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
633,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
633,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
633,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
633,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
633,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
633,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
633,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
633,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
634,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
634,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
634,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
634,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
634,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
634,6,Death,Death and sudden death,Fatal outcomes,Genrl,N
634,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
634,8,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
634,9,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
634,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
634,11,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
634,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
634,13,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
634,14,Headache,Headaches NEC,Headaches,Nerv,N
634,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
634,16,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
634,17,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
634,18,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
634,19,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
634,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,21,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
634,22,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
634,23,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
634,24,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
634,25,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
634,26,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
634,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
635,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
636,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
636,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
637,1,Periostitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
638,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
639,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
640,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
640,2,Disseminated mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
640,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
641,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
642,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
642,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
642,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
642,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
643,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
643,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
643,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
643,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
643,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
644,1,Disseminated mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
644,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
644,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
644,4,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
644,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
644,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
644,7,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
645,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
645,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
646,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
646,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
647,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
647,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
648,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
648,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
649,1,Acne,Acnes,Skin appendage conditions,Skin,N
649,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
649,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
650,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
650,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
651,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
651,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
651,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
651,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
652,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
652,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
653,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
653,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
653,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
653,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
654,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
654,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
655,1,Hypertrophic osteoarthropathy,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
656,1,Hypertrophic osteoarthropathy,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
657,1,Hypertrophic osteoarthropathy,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
658,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
658,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
659,1,Hypertrophic osteoarthropathy,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
660,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
660,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
661,1,Hypertrophic osteoarthropathy,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
661,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
662,1,Hypertrophic osteoarthropathy,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
663,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
664,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
664,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
665,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
665,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
666,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
666,2,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
666,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
667,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
667,2,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
667,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
668,1,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
669,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
670,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
670,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
671,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
672,1,Chromoblastomycosis,Cladosporidia infections,Fungal infectious disorders,Infec,N
672,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
672,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
673,1,Disorganised speech,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
673,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
673,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
673,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
673,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
673,6,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
673,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
674,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
675,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
676,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
676,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
